学术探索
学术期刊
新闻热点
数据分析
智能评审

Gene methylation and early detection of genitourinary cancer: the road ahead

被引：65
作者：
Cairns, Paul [1 ]
机构：
[1] Fox Chase Canc Ctr, Dept Surg Oncol & Pathol, Philadelphia, PA 19111 USA
来源：
NATURE REVIEWS CANCER | 2007年 / 7卷 / 07期
关键词：
D O I：
10.1038/nrc2170
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DNA methylation is a common mechanism of inactivation of tumour-suppressor and other cancer genes in neoplastic cells. The advantages of gene methylation as a target for the detection and diagnosis of cancer in biopsy specimens and non-invasive body fluids such as urine or blood has led to many studies of application in genitourinary cancer. Here, we consider the background, promise and status, challenges and future directions of gene methylation and its clinical utility for the early detection of genitourinary cancer. The challenges of, and strategies for, advancing gene-methylation-based detection are relevant to all types of cancer.
引用
收藏
页码：531 / 543
页数：13
相关论文
共 119 条
  • [81] Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer
    Machida, Emi Ota
    Brock, Malcolm V.
    Hooker, Craig M.
    Nakayama, Jun
    Ishida, Akiko
    Amano, Jun
    Picchi, Maria A.
    Belinsky, Steven A.
    Herman, James G.
    Taniguchi, Shun'ichiro
    Baylin, Stephen B.
    [J]. CANCER RESEARCH, 2006, 66 (12) : 6210 - 6218
  • [82] Mackay J, 2002, The tobacco atlas
  • [83] Molecular detection of primary bladder cancer by microsatellite analysis
    Mao, L
    Schoenberg, MP
    Scicchitano, M
    Erozan, YS
    Merlo, A
    Schwab, D
    Sidransky, D
    [J]. SCIENCE, 1996, 271 (5249) : 659 - 662
  • [84] Maruyama R, 2001, CANCER RES, V61, P8659
  • [85] Maruyama R, 2002, CLIN CANCER RES, V8, P514
  • [86] Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancer
    Millar, DS
    Ow, KK
    Paul, CL
    Russell, PJ
    Molloy, PL
    Clark, SJ
    [J]. ONCOGENE, 1999, 18 (06) : 1313 - 1324
  • [87] Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma
    Morris, MR
    Gentle, D
    Abdulrahman, M
    Maina, EN
    Gupta, K
    Banks, RE
    Wiesener, MS
    Kishida, T
    Yao, M
    Teh, B
    Latif, F
    Maher, ER
    [J]. CANCER RESEARCH, 2005, 65 (11) : 4598 - 4606
  • [88] Morrissey C, 2001, CANCER RES, V61, P7277
  • [89] Palmisano WA, 2000, CANCER RES, V60, P5954
  • [90] Global cancer statistics in the year 2000
    Parkin, DM
    [J]. LANCET ONCOLOGY, 2001, 2 (09) : 533 - 543
3456789101112